JPS60237360A - Inspection apparatus - Google Patents

Inspection apparatus

Info

Publication number
JPS60237360A
JPS60237360A JP59092936A JP9293684A JPS60237360A JP S60237360 A JPS60237360 A JP S60237360A JP 59092936 A JP59092936 A JP 59092936A JP 9293684 A JP9293684 A JP 9293684A JP S60237360 A JPS60237360 A JP S60237360A
Authority
JP
Japan
Prior art keywords
synthetic resin
general formula
testing
instrument according
resin container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59092936A
Other languages
Japanese (ja)
Inventor
Yoshimitsu Asada
浅田 善光
Takeshi Takebe
建部 健
Toru Takahashi
徹 高橋
Shunji Ichikawa
俊二 市川
Takeshi Shimomura
猛 下村
Shigeo Aoyanagi
重郎 青柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP59092936A priority Critical patent/JPS60237360A/en
Priority to DE8585105778T priority patent/DE3584188D1/en
Priority to EP19850105778 priority patent/EP0164583B1/en
Publication of JPS60237360A publication Critical patent/JPS60237360A/en
Priority to US07/018,051 priority patent/US4735832A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06Use of macromolecular materials
    • A61L33/068Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/15003Source of blood for venous or arterial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/153Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
    • A61B5/154Devices using pre-evacuated means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
    • B65D1/02Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0207Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by material, e.g. composition, physical features
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D23/00Details of bottles or jars not otherwise provided for
    • B65D23/08Coverings or external coatings
    • B65D23/0807Coatings
    • B65D23/0814Coatings characterised by the composition of the material
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04Coating
    • C08J7/0427Coating with only one layer of a composition containing a polymer binder
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04Coating
    • C08J7/048Forming gas barrier coatings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D4/00Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; Coating compositions, based on monomers of macromolecular compounds of groups C09D183/00 - C09D183/16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150389Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150473Double-ended needles, e.g. used with pre-evacuated sampling tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150732Needle holders, for instance for holding the needle by the hub, used for example with double-ended needle and pre-evacuated tube
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2483/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon only; Derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Clinical Laboratory Science (AREA)
  • Ceramic Engineering (AREA)
  • Analytical Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)

Abstract

PURPOSE:To improve the gas barrier property along with a higher transparency by making a specified silicon compound react with the inner or outer of a synthetic resin container to form a film with a continuous gas barrier. CONSTITUTION:The mixture of silicon compounds expressed by the formulas 1 and 2 is made to react with at least one of the inner and outer surfaces of a synthetic resin container body 2 to form a film with a continuous gas barrier property. Then, an inspection chemical agent 5a is housed into the body 2 and the opening is closed with a stickable plug member 4.

Description

【発明の詳細な説明】 10発明の背景 技術分野 本発明は、検査用器具に関するものである。詳しく述べ
るとガスバリヤ−性が極めて高くかつ透明性が良好で長
期間にわたって内部の検査用薬剤を変質させることがな
い検査用器具に関するものである。
DETAILED DESCRIPTION OF THE INVENTION 10. BACKGROUND TECHNICAL FIELD OF THE INVENTION The present invention relates to testing instruments. Specifically, the present invention relates to a testing instrument that has extremely high gas barrier properties, good transparency, and does not cause the internal testing agent to deteriorate over a long period of time.

先行技術 従来、診断のために血液またはその他の体液中の微生物
を培養したりあるいはこれらの血液または体液中の異常
成分を検出するために、検査用薬剤を容器に収納してな
る検査用器具が使用されて゛いる。−例を挙げると、例
えば、容器内に体液ないしゲル状培地、抗凝固剤等を収
納してなる検査用器具がある。
PRIOR ART Conventionally, in order to culture microorganisms in blood or other body fluids for diagnosis, or to detect abnormal components in these blood or body fluids, there have been test instruments that contain test agents in containers. It is used. - For example, there are test instruments that contain body fluids, gel-like media, anticoagulants, etc. in a container.

このような検査用器具としては、従来、容器本体として
ガス透過性がなくかつ透明性の良好なものとしてガラス
製容器が使用されてきた。しかしながら、ガラス製容器
は、保存または運搬中、もしくは使用中に破損しやすく
、また重いという欠点があった。このため、軽量で透明
な合成樹脂製容器の使用について検討を行なったが、合
成樹脂は大なり小なりガス透過性があるので、長期間の
保存中に周囲の雰囲気ガス、例えば空気(酸素ガス)が
透過してしまい、この結果、内部の検査用薬剤が変質す
るという欠点があった。例えば、合成樹脂製容器の内部
に酸化されやすい薬剤、例えば液体ないしゲル状培地、
抗凝固剤等が収納されていると、容器を透過して流入す
る周辺雰囲気の空気中に含まれている酸素により前記薬
剤が酸化されて変質を起こすため、合成樹脂製容器を採
用しようとすれば、減圧包装容器内に保存する必要があ
った。しかるに、減圧包装容器による保存は、包装容器
が減圧容器であるために、極めて高価であるうえに密封
および開缶で著しく手間がかかるのでコスト高となると
いう欠点があった。一方、前記検査用薬剤のうち水溶液
のものは、内部の水分が蒸発し、水蒸気として前記合成
樹脂製容器を透過するためその濃度が変化するという欠
点があった。
As such testing instruments, glass containers have conventionally been used because the container main body is not gas permeable and has good transparency. However, glass containers have the disadvantage that they are easily damaged during storage, transportation, or use, and are heavy. For this reason, we investigated the use of lightweight and transparent containers made of synthetic resin, but since synthetic resins are more or less gas permeable, during long-term storage they may be exposed to surrounding atmospheric gases, such as air (oxygen gas). ) is transmitted through the test tube, resulting in the deterioration of the test chemicals inside. For example, a chemical that is easily oxidized, such as a liquid or gel medium, inside a synthetic resin container.
If an anticoagulant or the like is stored, the oxygen contained in the surrounding air that passes through the container will oxidize the drug and cause deterioration, so it is difficult to use a synthetic resin container. For example, it was necessary to store it in a vacuum packaging container. However, storage in a reduced pressure packaging container has the disadvantage that, since the packaging container is a reduced pressure container, it is extremely expensive and requires considerable time and effort to seal and open the can, resulting in high costs. On the other hand, the aqueous solutions of the test chemicals have the disadvantage that the moisture inside evaporates and passes through the synthetic resin container as water vapor, resulting in a change in concentration.

■0発明の目的 したがって、本発明の目的は、新規な検査用器具を提供
することにある。本発明の他の目的は、液体ないしゲル
状培地、抗凝固剤等の薬液を収納したガスバリヤ−性が
高くかつ透明性が良好で長期間にわたって検査用薬液を
変質させることのない検査用器具を提供することにある
。本発明のさらに他の目的は、被損の恐れがなくかつガ
スバリヤ−性の極めて高い検査用器具を提供することに
ある。
■Object of the Invention Accordingly, an object of the present invention is to provide a novel testing instrument. Another object of the present invention is to provide a testing device that contains a liquid or gel medium, an anticoagulant, and other chemical solutions, has a high gas barrier property, has good transparency, and does not deteriorate the test chemical solution over a long period of time. It is about providing. Still another object of the present invention is to provide an inspection instrument that is free from damage and has extremely high gas barrier properties.

これらの開目的は、少なくとも一個所に密閉可能な開口
部を有する合成樹脂製容器本体の内表面または外表面の
少なくとも一方の表面に一般式I(ただし、式中、mは
1〜5の整数である。)を有するケイ素化合物と一般式
■ (ただし、式中、nは1〜5の整数であり、またR+お
よびR2は炭素原子数1〜4のアルキルまたはアルコキ
シ基、フェニル基または水酸基であるが、R’lおよび
R2が同時に水酸基であることはない。)を有するケイ
素化合物の混合物を反応させてガスバリヤ−性の連続し
た被膜を形成してなる合成樹脂製容器に検査用薬剤を収
納し、前記開口部を穿刺可能な栓部材で閉塞し内部に密
閉空間を形成してなる検査用器具により達成される。
The purpose of these openings is to form a synthetic resin container main body having a sealable opening in at least one place, on at least one of the inner and outer surfaces of the container body with the general formula I (where m is an integer of 1 to 5). ) and a silicon compound having the general formula ■ (where n is an integer of 1 to 5, and R+ and R2 are an alkyl or alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a hydroxyl group). (However, R'l and R2 are not hydroxyl groups at the same time.) A test agent is stored in a synthetic resin container made by reacting a mixture of silicon compounds having R'l and R2 to form a continuous film with gas barrier properties. However, this is achieved by a testing instrument in which the opening is closed with a plug member that can be pierced to form a sealed space inside.

′また、本発明は、合成樹脂製容器本体が透明合成樹脂
製である検査用器具である。さらに、本発明は、前記被
膜が透明被膜である検査用器具である。本発明は、前記
被膜が膜厚が0.01〜2゜0μ童である検査用器具で
ある。また、本発明は、一般式■におけるmが1〜5の
整数であり、かつ一般式■におりるnが1〜5の整数で
あり、またR1およびR2が炭素原子数1〜4のアルキ
ル基または水酸基である検査用器具である。さらに、本
発明は、一般式■におけるR1が炭素原子数1〜2のア
ルキル基であり、かつR2が水酸基である検査用器具で
ある。本発明は、検査用薬剤が酸化性物質である検査用
器具である。また、本発明は、酸化性物質が液体ないし
ゲル状培地である検査用器具である。さらに、本発明は
、酸化性物質が抗凝固剤である検査用器具である。また
、本発明は、密閉空間が大気圧より減圧状態である検査
用器具である。
'Furthermore, the present invention is an inspection instrument in which the synthetic resin container body is made of transparent synthetic resin. Furthermore, the present invention is an inspection instrument in which the coating is a transparent coating. The present invention is an inspection instrument in which the coating has a thickness of 0.01 to 2.0 μm. Further, the present invention provides a method in which m in the general formula (1) is an integer of 1 to 5, n in the general formula (2) is an integer of 1 to 5, and R1 and R2 are alkyl having 1 to 4 carbon atoms. It is an instrument for testing whether it is a group or a hydroxyl group. Furthermore, the present invention is an inspection instrument in which R1 in the general formula (2) is an alkyl group having 1 to 2 carbon atoms, and R2 is a hydroxyl group. The present invention is a testing instrument in which the testing agent is an oxidizing substance. Further, the present invention is a test instrument in which the oxidizing substance is a liquid or gel-like medium. Furthermore, the present invention is a test instrument in which the oxidizing substance is an anticoagulant. Further, the present invention is an inspection instrument in which the closed space has a pressure lower than atmospheric pressure.

■0発明の具体的構成 つぎに、図面を参照しながら本発明の詳細な説明する。■Specific structure of 0 invention Next, the present invention will be described in detail with reference to the drawings.

すなわち、第1図は減圧採取方式による検査用器具の一
例を示すもので、この検査用器具1は、少なくとも一個
所に密閉可能な開口部3を有する透明合成樹脂製容器本
体2と、該容器本体2の開口部3を密閉した栓部材4と
なり、該容器本体2内の空間5に検査用薬剤5aを収納
してなるものである。しかして、この空間5は減圧され
、さらに前記検査用薬剤に対して不活性なガスの雰囲気
下に保持されることが好ましい。また、前記透明合成樹
脂製容器本体2の内表面および外表面の少なくとも一方
の表面に前記一般式Iおよび■のケイ素化合物をプラズ
マ処理により反応させて透明被膜が形成される。例えば
、第2(A)図に示すように、容器本体2の外表面全面
に前記ケイ素化合物を反応させて透明被膜2aが形成さ
れている。また、第2(B)図に示すように、容器本体
2の内表面全面に前記透明被膜2bが形成されている。
That is, FIG. 1 shows an example of a test instrument using a reduced pressure sampling method. This is a plug member 4 that seals an opening 3 of a main body 2, and a test agent 5a is stored in a space 5 within the container main body 2. Therefore, it is preferable that this space 5 is depressurized and further maintained under an atmosphere of gas inert to the testing agent. Further, a transparent film is formed on at least one of the inner and outer surfaces of the transparent synthetic resin container body 2 by reacting the silicon compounds of the general formulas I and (2) with plasma treatment. For example, as shown in FIG. 2A, a transparent coating 2a is formed on the entire outer surface of the container body 2 by reacting the silicon compound. Further, as shown in FIG. 2(B), the transparent coating 2b is formed on the entire inner surface of the container body 2.

さらに、第2(C)図に示すように、容器本体2の外表
面に前記透明被膜2aがまたその内表面に前記透明被膜
2bが形成されている。なお、第2(A)〜2(C)図
において、透明被膜2a、2bの膜厚は誇張して画かれ
ている。
Furthermore, as shown in FIG. 2(C), the transparent coating 2a is formed on the outer surface of the container body 2, and the transparent coating 2b is formed on the inner surface thereof. In addition, in FIGS. 2(A) to 2(C), the thicknesses of the transparent coatings 2a and 2b are exaggerated.

本発明で使用される管状部材を構成する合成樹脂は特に
限定されるものではないが、透明合成樹脂が好ましく、
特にスチレンの単独重合体または′ 共重合体、メチル
メタクリレートの単独重合体または共重合体、ポリカー
ボネート等が好ましい。
The synthetic resin constituting the tubular member used in the present invention is not particularly limited, but transparent synthetic resin is preferable;
Particularly preferred are styrene homopolymers or copolymers, methyl methacrylate homopolymers or copolymers, polycarbonates, and the like.

スチレン重合体としては、ポリスチレンの他にスチレン
と他の共重合性単量体との共重合体があり、該共重合性
単量体としては、ブタジン、メチルメタクリレート、無
水マレイン酸等のうちの少なくとも一種のものがある。
In addition to polystyrene, styrene polymers include copolymers of styrene and other copolymerizable monomers, such as butazine, methyl methacrylate, maleic anhydride, etc. There is at least one kind of thing.

被膜形成成分の一つは一般式■ (ただし、式中、mは1〜5、好ましくは1〜2の整数
である。)を有するケイ素化合物である。
One of the film-forming components is a silicon compound having the general formula (1) (where m is an integer of 1 to 5, preferably 1 to 2).

他方の被膜形成成分は一般式■ を有するケイ素化合物である。該一般式■において、n
は1〜5、好ましくは1〜2の整数である。
The other film-forming component is a silicon compound having the general formula (2). In the general formula (■), n
is an integer of 1 to 5, preferably 1 to 2.

またR1およびR2は炭素原子数1〜4のアルキルまた
はアルコキシ基、フェニル基または水酸基であるが、R
1およびR2が同時に水酸基であることはない。R1お
よびR2は、好ましくは炭素原子数1〜4のアルキル基
または水酸基であるが、両者が水酸基であることはなく
、特にR1が炭素原子数1〜2のアルキル基で、R2が
水酸基である場合が好ましい。
R1 and R2 are alkyl or alkoxy groups having 1 to 4 carbon atoms, phenyl groups or hydroxyl groups, but R
1 and R2 are never hydroxyl groups at the same time. R1 and R2 are preferably an alkyl group having 1 to 4 carbon atoms or a hydroxyl group, but both are not hydroxyl groups, and in particular R1 is an alkyl group having 1 to 2 carbon atoms and R2 is a hydroxyl group. The case is preferred.

しかして、一般式Iのケイ素化合物1モルに対する一般
式■のケイ素化合物の配合比は0.5〜3モル、好まし
くは1〜2である。このようなケイ素化合物の混合物は
、メタノール、エタノール、イソプロパツール等の有機
溶媒の溶液として使用される。その濃度は、3〜50重
量%、好ましくは5〜35重量%である。
Therefore, the blending ratio of the silicon compound of the general formula (2) to 1 mole of the silicon compound of the general formula (I) is 0.5 to 3 moles, preferably 1 to 2 moles. Such mixtures of silicon compounds are used as solutions in organic solvents such as methanol, ethanol, isopropanol, etc. Its concentration is 3-50% by weight, preferably 5-35% by weight.

前記透明被膜は、つぎのようにして形成される。The transparent film is formed as follows.

例えば、管状部材2の開口@13を栓部材4あるいはそ
の他の閉塞部材ないし掬塞治具(図示せず)を用いて閉
塞したのち、前記ケイ素化合物の混合溶液中に浸漬して
前記管状部材2の外表面に付着させる。この浸漬時間は
、通常0.01〜10分、りYましくは1〜5分である
。なお、この場合、浸漬中に超音波を当てながら行なう
と、合成樹脂製管状部材表面の微細孔からの空気抜きと
該微細孔への溶質の侵入が促進されるので、生成する被
膜のカスバリヤー性が向上する。なお、前記混合溶液の
塗布は浸漬のみに限られるのではなく、スプレーその他
の方法で行なうこともできる。
For example, after the opening @ 13 of the tubular member 2 is closed using the plug member 4 or other closing member or occluder (not shown), the tubular member 2 is immersed in the mixed solution of the silicon compound. adhere to the outer surface of the The immersion time is usually 0.01 to 10 minutes, preferably 1 to 5 minutes. In this case, applying ultrasonic waves during dipping will promote the removal of air from the micropores on the surface of the synthetic resin tubular member and the infiltration of solutes into the micropores, thereby improving the gas barrier properties of the resulting film. improves. Note that the application of the mixed solution is not limited to dipping, but can also be performed by spraying or other methods.

浸漬処理の温度は、通常O〜50°C好ましくは10−
30℃である。また、超音波の作用下に行なう場合には
、0〜50℃、好ましくは10〜30℃の液温で20〜
2’0OK)−1z、好ましくは25〜50 K HZ
の周波数で0.1〜10分間、好ましくは0.5〜5分
間行なわれる。
The temperature of the immersion treatment is usually 0 to 50°C, preferably 10-50°C.
The temperature is 30°C. In addition, when carrying out under the action of ultrasonic waves, the liquid temperature is 0 to 50°C, preferably 10 to 30°C, and 20 to 20°C.
2'0OK)-1z, preferably 25-50 K Hz
It is carried out at a frequency of 0.1 to 10 minutes, preferably 0.5 to 5 minutes.

このようにして前記8合溶液を塗布された管状部材は、
50〜120℃、好ましくは60〜70℃の温度で3〜
30分間、好ましくは5〜15分間乾燥されたのち、プ
ラズマ処理に供される。
The tubular member coated with the 8-solution solution in this way is
3 to 3 at a temperature of 50 to 120°C, preferably 60 to 70°C.
After being dried for 30 minutes, preferably 5 to 15 minutes, it is subjected to plasma treatment.

前記管状部材表面の塗膜をプラズマ処理して透明被膜を
形成させるには、例えば、つぎのようにして行なう。す
なわら、第3図に示すようにガス導入口11およびガス
排出口12を備えた反応器13に、電極14を設け、該
電極14には管状部材支持具15を設置プ、該管状部材
支持具15に前記混合溶液を塗布した管状部材2を支持
させる。
The coating film on the surface of the tubular member is plasma-treated to form a transparent film, for example, in the following manner. That is, as shown in FIG. 3, an electrode 14 is provided in a reactor 13 equipped with a gas inlet 11 and a gas outlet 12, and a tubular member support 15 is installed on the electrode 14. The support 15 supports the tubular member 2 coated with the mixed solution.

例えば、密栓除去後の管状部材2の内部に管状部材支持
具15を挿入して支持させる。なお、電極14には、冷
fA装置16,1を当接さけるとともに該冷却装置16
aは温度調節器16bに連結されて冷却媒体、例えば水
が循環される。また、電極14にはアース17が連結さ
れる。一方、電極14の対面には対極18が設けられ、
該対極18は整合器1つを経て高周波電源20に連結さ
れている。ガス導入口11には、酸素容器21および流
量計22が連結されている。一方、ガス排出口12には
、トラップ23を経て油拡散ポンプ24、油回転ポンプ
25等の減圧装置が連結されている。
For example, the tubular member support 15 is inserted and supported inside the tubular member 2 after the seal is removed. Note that the cooling fA device 16, 1 should not be brought into contact with the electrode 14, and the cooling device 16 should not be brought into contact with the electrode 14.
a is connected to a temperature controller 16b to circulate a cooling medium such as water. Further, the electrode 14 is connected to a ground 17 . On the other hand, a counter electrode 18 is provided on the opposite side of the electrode 14,
The counter electrode 18 is connected to a high frequency power source 20 through one matching box. An oxygen container 21 and a flow meter 22 are connected to the gas inlet 11 . On the other hand, pressure reducing devices such as an oil diffusion pump 24 and an oil rotary pump 25 are connected to the gas discharge port 12 via a trap 23 .

なお、第3図において、符号26は圧力センサー、符号
27は真空ゲージであり、また符号28は温度計である
In FIG. 3, reference numeral 26 is a pressure sensor, 27 is a vacuum gauge, and 28 is a thermometer.

しかして、油回転ポンプ等の減圧装置を作動させてガス
排気口12から反応器13内の雰囲気ガスを排気して所
定の減圧度を保ちつつ前記酸素ガスを酸素容器21力目
ら流量計22を経てガス導入口11より反応器13に供
給しながら電極に通電してプラズマを前8e塗布面に照
射して処理する。
Then, a pressure reducing device such as an oil rotary pump is operated to exhaust the atmospheric gas in the reactor 13 from the gas exhaust port 12, and while maintaining a predetermined degree of pressure reduction, the oxygen gas is transferred from the oxygen container 21 to the flow meter 22. While supplying the gas through the gas inlet 11 to the reactor 13, the electrodes are energized to irradiate plasma onto the coated surface 8e for treatment.

この場合、塗面に一様にプラズマが照射されるように1
例えば、容器本体を回転しながら照射を行なうことが望
ましい。
In this case, 1
For example, it is desirable to perform irradiation while rotating the container body.

プラズマ処理時の反応器内の圧力はo、oi〜2、 □
Horr 、好ましくは0.1〜0.5Torrである
。基盤である電極14は冷却装置16aに循環される冷
却媒体より冷却されているが、反応器内の温度は0〜1
50℃、好ましくは30〜70℃である。また、高周波
電力量は0.05〜2゜0W/cm2、好ましくは0.
 2〜1 、5W/cm2である。さらに酸素原子含有
分子のガスとしては一分子状酸素、オゾン、−酸化炭素
、炭酸ガス、−酸化窒素、−酸化二窒素及びこれらと他
のカス(例えばアルゴン、窒素ヘリウムなど)との混合
ガス等があるが、好ましくは分子状酸素(以下、i!素
ガスという。〉であり、酸素含有量は20〜100%で
あることが好ましい。プラズマ照射は、0.1〜60分
間、好ましくは0.3〜5分間照射する。よって基材で
ある管状部材のプラズマ照射による温度上昇が防止でき
るので、好適である。
The pressure inside the reactor during plasma treatment is o, oi~2, □
Torr, preferably 0.1 to 0.5 Torr. The electrode 14, which is the base, is cooled by a cooling medium circulated in the cooling device 16a, but the temperature inside the reactor is between 0 and 1.
The temperature is 50°C, preferably 30-70°C. Further, the high frequency power amount is 0.05 to 2°0 W/cm2, preferably 0.05 to 2°0 W/cm2.
2 to 1,5 W/cm2. Furthermore, gases containing oxygen atoms include monomolecular oxygen, ozone, carbon oxide, carbon dioxide, nitrogen oxide, dinitrogen oxide, and mixed gases of these and other gases (e.g., argon, nitrogen helium, etc.). However, it is preferably molecular oxygen (hereinafter referred to as i! elementary gas), and the oxygen content is preferably 20 to 100%.The plasma irradiation is performed for 0.1 to 60 minutes, preferably 0. The irradiation is carried out for 3 to 5 minutes.This is preferable since it is possible to prevent the temperature of the tubular member, which is the base material, from increasing due to the plasma irradiation.

このような反応条件下に形成される透明被膜の膜厚は0
.01〜2.0μ丑、好ましくは0.03〜0.2μm
である。
The thickness of the transparent film formed under these reaction conditions is 0.
.. 01~2.0μm, preferably 0.03~0.2μm
It is.

本発明方法は、ケイ素化合物の混合溶液塗布前に、開口
部閉塞前または閉塞後に管状部材を洗浄処理に供すれば
、さらに、良好な結果かjqられる。
In the method of the present invention, better results can be obtained if the tubular member is subjected to a cleaning treatment before or after closing the opening before applying the mixed solution of the silicon compound.

洗浄は、水、酸水溶液、アルカリ水溶液、アルコール、
界面活性剤水溶液等を用いて行なわれるが、アルカリ水
溶液が好ましい。アルカリ水溶液としては、炭酸ナトリ
ウム、炭酸カリウム、炭酸リチウム、炭酸水素ナトリウ
ム、水酸化ナトリウム、水酸カリウム等があり、通常0
.1〜20重量%、好ましくは3〜10重量%の水溶液
として用いられる。その処理時間は、通常0.1〜30
分間、好ましくは5〜10分間であり、その液温は0〜
150℃、好ましくは10〜40℃である。また、前記
洗浄処理は、超音波の作用により行なえば、さらに良好
な結果が得られる。超音波処理は、20〜200KHz
、好ましくは25〜50KHzの周波数で0.1〜10
分間、好ましくは0.5〜5分間行なわれる。超音波に
より洗浄処理を行なえば、アルカリ水溶液以外の処理剤
であってもかなり良好な結果が得られることはもちろん
である。また、アルカリ水溶液を用いて超音波洗浄を行
なえば、最も良好な結果が得られる。
Cleaning can be done with water, acid aqueous solution, alkaline aqueous solution, alcohol,
This is carried out using an aqueous surfactant solution, but an alkaline aqueous solution is preferred. Examples of alkaline aqueous solutions include sodium carbonate, potassium carbonate, lithium carbonate, sodium hydrogen carbonate, sodium hydroxide, potassium hydroxide, etc.
.. It is used as an aqueous solution of 1 to 20% by weight, preferably 3 to 10% by weight. The processing time is usually 0.1 to 30
minutes, preferably 5 to 10 minutes, and the liquid temperature is 0 to 10 minutes.
The temperature is 150°C, preferably 10-40°C. Furthermore, even better results can be obtained if the cleaning treatment is performed using ultrasonic waves. Ultrasonic treatment is 20-200KHz
, preferably 0.1-10 at a frequency of 25-50 KHz
This is carried out for 0.5 to 5 minutes, preferably 0.5 to 5 minutes. It goes without saying that if cleaning treatment is carried out using ultrasonic waves, fairly good results can be obtained even with treatment agents other than aqueous alkaline solutions. Furthermore, the best results can be obtained by performing ultrasonic cleaning using an alkaline aqueous solution.

栓部材4を構成する材料としては、ブチルゴム以外に後
述するように、使用時に採血針の穿刺が可能でかつ該採
血針の穿刺により採血針の栓部材との間が緩まないだけ
の充分な弾性を有し、さらにガス透過性の低いものが望
ましい。その代表的なものとしては、例えば熱可塑性エ
ラストマーとポリイソブチレンと部分架橋ブチルゴムと
の配合物等があり、好ましくは熱可塑性エラストマーと
ポリイソブチレンと部分架橋ブチルゴムとの配合物であ
る。
In addition to butyl rubber, the material constituting the plug member 4 may include materials with sufficient elasticity to allow the blood collection needle to be inserted during use and to prevent the gap between the blood collection needle and the plug member from loosening due to the puncture of the blood collection needle, as will be described later. It is desirable that the material has a low gas permeability. Typical examples thereof include, for example, a blend of a thermoplastic elastomer, polyisobutylene, and partially crosslinked butyl rubber, and preferably a blend of a thermoplastic elastomer, polyisobutylene, and partially crosslinked butyl rubber.

該配合物における各成分の組成は、熱可塑性エラストマ
ー100重量部当りポリイソブチレン100〜200重
量部、好ましくは120〜150重量部であり、部分架
橋ブチルゴム100〜200重量部、好ましくは120
〜150重量部である。
The composition of each component in the formulation is 100 to 200 parts by weight, preferably 120 to 150 parts by weight, of polyisobutylene per 100 parts by weight of thermoplastic elastomer, and 100 to 200 parts by weight, preferably 120 parts by weight, of partially crosslinked butyl rubber.
~150 parts by weight.

熱可塑性エラストマーとしては、エチレン−プロピレン
ゴム系、ポリエステルエラストマー、ナイロンエラスト
マー系、スヂレンーイソプレンブロック共重合体、スチ
レン−ブタジェンブロック共重合体、ポリブタジェン、
熱可塑性ポリウレタン、水素添加スチレン−ブタジェン
ブロック共重合体等がある。ポリイソブチレンは、分子
量15゜000〜200,000.好ましくは80,0
00〜150.000のものである。部分架橋ブチルゴ
ムは、イソブチレンと少量(例えば0.3〜3.0モル
%)のイソプレンと共重合させて得られるブチルゴムを
部分架橋してなるものである。
Examples of thermoplastic elastomers include ethylene-propylene rubber, polyester elastomer, nylon elastomer, styrene-isoprene block copolymer, styrene-butadiene block copolymer, polybutadiene,
Examples include thermoplastic polyurethane, hydrogenated styrene-butadiene block copolymer, and the like. Polyisobutylene has a molecular weight of 15°000 to 200,000. Preferably 80,0
00 to 150.000. Partially crosslinked butyl rubber is obtained by partially crosslinking butyl rubber obtained by copolymerizing isobutylene with a small amount (for example, 0.3 to 3.0 mol%) of isoprene.

このようにして得られる合成樹脂製容器には、検査用薬
剤6が収納され、その内部空間5が減圧状態または窒素
、アルゴン、ヘリウム、炭酸ガス等の不活性ガス雰囲気
下にされて、前記開口部3には栓部材4が閉塞される。
The test agent 6 is stored in the synthetic resin container thus obtained, and the internal space 5 is brought into a reduced pressure state or an inert gas atmosphere such as nitrogen, argon, helium, carbon dioxide, etc., and the opening is opened. The portion 3 is closed with a plug member 4.

検査用薬剤としては、各種液体ないしゲル状培地、抗凝
固剤、例えばエチレンジアミン四酢酸塩、シュウ酸ナト
リウム、CPD液、ACD−A液等がある。
Testing agents include various liquid or gel media, anticoagulants such as ethylenediaminetetraacetate, sodium oxalate, CPD solution, ACD-A solution, and the like.

このようにして得られる検査用器具は、前記検査用薬剤
収納前または収納後に滅菌される。滅菌は、水蒸気滅菌
、放射線滅菌等が採用できるが、好ましくは放射性滅菌
である。この場合、使用される放射線としてはガンマ線
、電子線等の電!!放射線があり、好ましくはガンマ線
であり、その照射強度は0.1〜4Mrad 、好まし
くは0.5〜2.5Mrad でaる。
The test instrument thus obtained is sterilized before or after storing the test drug. For sterilization, steam sterilization, radiation sterilization, etc. can be used, but radiation sterilization is preferable. In this case, the radiation used is gamma rays, electron beams, etc. ! There is radiation, preferably gamma rays, the irradiation intensity of which is between 0.1 and 4 Mrad, preferably between 0.5 and 2.5 Mrad.

■3発明の具体的作用 以上のごとき構成を有する減圧採取管は、っぎのように
して使用される。すなわち、第4図に示すように一端が
閉塞しかつ他端が開口し、該閉塞端部6のねじ穴7内に
前記開口部が嵌挿する。この採取針8は、例えば血管刺
通部8aと栓穿刺部8bとよりなり、該栓穿刺部8bに
は合成樹脂製のルアーアダプター10で包装されている
。ついで、採取針8の血管刺通部8aを血管、例えば静
脈に刺通し、さらに減圧採血笛1を採血管ホルタ−9の
閉塞部6へ抑圧挿入すると、第5図に示すように採取管
8の栓穿刺部8bがルアーアダプタ−10および栓部材
4を穿刺してその先端部が採取管1の内部空間5に達す
るので、血管と該内部空間5とが連通し、該内部空間5
内の負圧により血管内の血液は減圧度に相当するだけ採
取管1の内部空間5内に流入する。ついで、採取針8の
血管刺通部8aを血管より外すことにより採面が終了す
る。この場合、被検体ないし被培養物が嫌気性であれば
、そのまま、また好気性であれば開栓ないしは酸素ない
し空気を導入することにより検査ないし培養が行なわれ
る。
(3) Specific effects of the invention The reduced pressure collection tube having the above configuration is used as described below. That is, as shown in FIG. 4, one end is closed and the other end is open, and the opening is inserted into the screw hole 7 of the closed end 6. The collection needle 8 is composed of, for example, a blood vessel piercing part 8a and a plug puncturing part 8b, and the plug puncturing part 8b is wrapped with a luer adapter 10 made of synthetic resin. Next, the blood vessel piercing portion 8a of the sampling needle 8 is pierced into a blood vessel, for example, a vein, and the reduced pressure blood sampling whistle 1 is inserted under pressure into the occluded portion 6 of the blood sampling tube holter 9. As shown in FIG. The plug puncturing part 8b punctures the Luer adapter 10 and the plug member 4, and the tip thereof reaches the internal space 5 of the collection tube 1, so that the blood vessel and the internal space 5 communicate with each other, and the internal space 5
Due to the negative pressure within the blood vessel, blood within the blood vessel flows into the internal space 5 of the collection tube 1 in an amount corresponding to the degree of reduced pressure. Next, the blood vessel piercing portion 8a of the sampling needle 8 is removed from the blood vessel, thereby completing the surface sampling. In this case, if the subject or cultured material is anaerobic, the test or culture is performed as is, or if it is aerobic, the test or culture is performed by opening the cap or introducing oxygen or air.

つぎに、実施例を挙げて本発明をさらに詳細に説明する
Next, the present invention will be explained in more detail by giving examples.

実施例1 ポリエチレンテレフタレート製有底チューブを濃度2.
5%のNa2CO3溶液中に5分間浸漬(超音波処理を
行った)したのち上述のケイ素化合物′a度12重量%
イソプロパツール溶液中に20℃、1分間浸漬したのち
、引き上げ速度16cm77分で引き上げた。次いで、
70’Cで30分間乾燥した。次いで、低温プラズマ反
応装置第3図13中に、当該合成樹脂製チューブを挿入
し、脱気(0,05Torr ) L、、次イテ、Ff
 素カフ、 ヲHTんして約0.3Torr圧力下で、
プラズマ出力電力100W、2分間プラズマ処理を平行
平板電極(50mmx50m平板使用)、距離的5Qm
mで行ったところ、このチューブの片面に膜厚が0.1
μmの透明被膜が被着した。この被覆チューブの酸素お
よび炭酸ガスの透過性を測定するため前記材質のフィル
ム(膜厚12μm1面積500m2)を用いて前記と同
様の処理を行なった。この被覆フィルムのガス透過性を
リッジ−社製気体透過測定装置で測定したところ50.
6m/!/m2 ・day−atmおよび204 ml
 /m 2 − day −atomてあった。
Example 1 A bottomed tube made of polyethylene terephthalate was prepared at a concentration of 2.
After immersing in a 5% Na2CO3 solution for 5 minutes (with ultrasonication), the above silicon compound'a concentration was 12% by weight.
After being immersed in an isopropanol solution at 20° C. for 1 minute, it was pulled up at a pulling speed of 16 cm for 77 minutes. Then,
Dry at 70'C for 30 minutes. Next, the synthetic resin tube was inserted into the low-temperature plasma reactor (Fig. 3, 13) and degassed (0.05 Torr).
With bare cuff, under pressure of about 0.3 Torr,
Plasma output power 100W, plasma treatment for 2 minutes using parallel plate electrodes (50mm x 50m flat plate used), distance 5Qm
m, the film thickness was 0.1 on one side of this tube.
A transparent film of μm was deposited. In order to measure the oxygen and carbon dioxide permeability of this coated tube, the same treatment as above was carried out using a film of the above material (film thickness: 12 μm, area: 500 m 2 ). The gas permeability of this coating film was measured using a gas permeation measuring device manufactured by Ridge Co., Ltd. and was 50.
6m/! /m2 ・day-atm and 204 ml
/m2-day-atom.

以下、実施例のガス透過性は全て別途フィルムを用意し
て同様に行なった。
Hereinafter, all the gas permeability tests in the Examples were conducted in the same manner using separate films.

この容器に第1表に示す培地を入れ、熱可塑性エラスト
マー(1,2−ポリブタジェン〉25重量部、ポリイソ
ブヂレン(分子量100,000>35重量部および部
分架橋ブチルゴム25重量部、流動パラフィン15重量
部よりなる配合物で作られた栓部材で減圧状態下に密栓
した後に1.4Mradのガンマ線で滅菌した。その結
果は、3力月間大気中にtiIy、置したが、培地の変
質はなくまた、減圧量もほとんど変化がなかった。
The culture medium shown in Table 1 was placed in this container, and 25 parts by weight of thermoplastic elastomer (1,2-polybutadiene), 25 parts by weight of polyisobutylene (molecular weight 100,000>35 parts by weight, 25 parts by weight of partially crosslinked butyl rubber, and 15 parts by weight of liquid paraffin) were added. It was sterilized with gamma rays of 1.4 Mrad after being sealed under reduced pressure with a stopper made of a compound of There was almost no change in the amount.

第1表 トリプトン 17(] 大豆ペプトン 3g 肉エキス 3g 、イーストエキス 5g 肝氷解物 19 グルコース 2・5g リン酸水素カリウム 2.5゜ 塩化ナトリウム 5g L−システィン塩酸塩 0.45g P−アミノ安息香酸 0.05Q ボリアネトールサルフAネイトナトリウム0、35(] ヘミン 0,005g 寒天 0.o1g ゼラチン 12g 蒸溜水 1,000蛮1 pH7,3±0.1 実施例2 実施例1と同様な方法において、濃度5重量%の混合溶
液を用い、5分間超音波処理したものについて70℃で
3分間乾燥し、直ちに同様な条例下にプラズマ処理を行
なったところ、膜厚0.04μmの透明被膜が形成され
た。酸素および炭酸ガスの透過性は、それぞれ28およ
び313であった。
Table 1 Tryptone 17 (] Soybean peptone 3g Meat extract 3g, Yeast extract 5g Liver ice melt 19 Glucose 2.5g Potassium hydrogen phosphate 2.5° Sodium chloride 5g L-cysteine hydrochloride 0.45g P-aminobenzoic acid 0 .05Q Borianetholsulfate A nate sodium 0,35 (] Hemin 0,005g Agar 0.01g Gelatin 12g Distilled water 1,000ml pH 7,3±0.1 Example 2 In the same method as Example 1, the concentration When a 5% by weight mixed solution was ultrasonically treated for 5 minutes, dried at 70°C for 3 minutes, and immediately subjected to plasma treatment under the same conditions, a transparent film with a thickness of 0.04 μm was formed. The oxygen and carbon dioxide permeabilities were 28 and 313, respectively.

比較例1 実施例1で使用されたポリエチレンテレフタレートの無
処理物の酸素および炭酸ガスの透過性G、tそれぞれ2
31および939であった。
Comparative Example 1 Oxygen and carbon dioxide gas permeability G and t of the untreated polyethylene terephthalate used in Example 1 were 2, respectively.
31 and 939.

比較例2 実施例1の方法において超音波処理およびプラズマ処理
を行なわずに32重石%の混合溶液中に5分間浸漬した
のち、60℃で180分間乾燥したところ、膜厚0.1
4μmの透明被膜が形成された。酸素および炭酸ガスの
透過性はそれぞれ213および854であった。
Comparative Example 2 In the method of Example 1, the film was immersed for 5 minutes in a mixed solution containing 32% iron without performing ultrasonic treatment or plasma treatment, and then dried at 60° C. for 180 minutes, resulting in a film thickness of 0.1
A transparent film of 4 μm was formed. The oxygen and carbon dioxide permeabilities were 213 and 854, respectively.

実施例3〜12 実施例1と同様に膜厚12μm (ただし、実施例8〜
12においては膜厚11.5μm)のポリエチレンテレ
フタレートフィルム(面積50cm2)を、第2表に示
す処理剤を用いて超音波洗浄したのち、乾燥処理を施し
た。ついで、実施例1と同様なケイ素化合物の混合溶液
を第2表に示?1′濃度で使用し、該混合溶液中に5分
間浸漬して、その間KHzの周波数で超音波処理を行な
ったのち、70℃で5分間乾燥を行なった。ついで、第
2表に示す出力数および時間て0.18Torrの条件
下においてプラズマ処理を行なったところ、第2表の結
果が得られた。
Examples 3 to 12 Same as Example 1, film thickness 12 μm (Examples 8 to 12)
In No. 12, a polyethylene terephthalate film (area: 50 cm 2 ) with a film thickness of 11.5 μm was ultrasonically cleaned using the treatment agent shown in Table 2, and then dried. Next, a mixed solution of silicon compounds similar to that in Example 1 is shown in Table 2. The sample was used at a concentration of 1', immersed in the mixed solution for 5 minutes, subjected to ultrasonication at a frequency of KHz, and then dried at 70° C. for 5 minutes. Next, plasma treatment was performed under the conditions of 0.18 Torr and the output numbers shown in Table 2, and the results shown in Table 2 were obtained.

(以下余白) 実施例13 第1図に示すように、一端が閉塞しがっ他端が開口した
肉厚immの管状容器2をポリエチレンテレフタレート
で作った。この管状容器を5%炭酸ナトリウム水溶液中
で1時間超音波処理したのち、60℃の温度で15分間
乾燥した。ついで、実施例1と同様なケイ素化合物の1
2重量%の濃度の混合溶液中に5分間浸漬して45 K
 Hzの周波数で超音波処理したのち、70℃の温度で
15分間乾燥した。さらに、200Wの出力数で酸素ガ
スの存在下に5分間でプラズマ処理を行なって透明な0
.07μmの被膜を外面に有する合成樹脂製容器を得た
。この容器に第3図に示す培地を入れ、熱可塑性エラス
トマー(1,2−ポリブタジェン)25重量部、ポリイ
ンブチレン(分子量100゜000>35重a81′5
および部分架橋ブチルゴム25重量部、流動パラフィン
15重量部よりなる配合物で作られた栓部材で減圧状態
下にして密栓した後に、1.5Mradのガンマ線で滅
菌した。その結果は3力月間人気中に放置したが、培地
の変質はなくまた、減圧量もほとんど変化がなかった。
(The following is a blank space) Example 13 As shown in FIG. 1, a tubular container 2 having a wall thickness of imm and having one end closed and the other end open was made of polyethylene terephthalate. This tubular container was subjected to ultrasonic treatment in a 5% aqueous sodium carbonate solution for 1 hour, and then dried at a temperature of 60° C. for 15 minutes. Then, 1 of the same silicon compound as in Example 1 was added.
45 K by immersion in a mixed solution with a concentration of 2% by weight for 5 minutes.
After ultrasonication at a frequency of Hz, drying was performed at a temperature of 70° C. for 15 minutes. Furthermore, plasma treatment was performed for 5 minutes in the presence of oxygen gas at a power output of 200 W to obtain a transparent zero.
.. A synthetic resin container having a coating of 0.07 μm on the outer surface was obtained. The culture medium shown in Fig. 3 was placed in this container, and 25 parts by weight of thermoplastic elastomer (1,2-polybutadiene) and polyimbutylene (molecular weight 100°000>35 weight a81'5) were added.
The container was sealed under reduced pressure with a stopper member made of a mixture of 25 parts by weight of partially cross-linked butyl rubber and 15 parts by weight of liquid paraffin, and then sterilized with gamma rays at 1.5 Mrad. The results showed that there was no change in the quality of the culture medium and there was almost no change in the amount of pressure reduction even though it was left for three months.

(以下余白) 第3表 トリプトン 179 大豆ペプトン 3Q 肉エキス 3Q イーストエキス 5g 肝氷解物 1g グルコース 2.5g リン酸水素カリウム 2.5g 塩化ナトリウム 5g し一システィン塩酸塩 0.45g P−アミノ安息香酸 o、 059 ポリアネトールサルフオネイトナトリウム0、35g ヘミン o、oosg 寒天 0.01g ゼラチン i2g 蒸溜水 i、ooomλ DH7,3±0.1 ■0発明の具体的効果 以上述べたように、本発明は、少なくとも1個所に密閉
可能な開口部を有する合成樹脂製容器本体の内表面また
は外表面の少なくとも一方の表面に一般式■を有するケ
イ素化合物と一般式■を有するケイ素化合物の混合物を
反応さけてカスバリヤー性の連続した被膜を形成してな
る合成樹脂製容器に検査用薬剤を収納し、前記開口部を
穿刺可能な栓部材で閉塞し内部に密封空間を形成してな
る検査用器具であるから、カス透過性、特に酸素ガス透
過係数が極めて低く、このため該検査用器具外から器具
内へのガス透過ならびに器具内から器具外へのガス透過
は実質的になくなる。したがって、培地や抗凝固剤等の
ごとき酸素により変質しやすい検査用薬剤を収納して使
用する場合、該器具外から器具内へのガス、特に酸素の
透過は実質的になくなり、このため長期間にわたって検
査用薬剤の変質はなくなる。また、水溶液として収納さ
れている検査用薬剤の場合には、水分が蒸発しても、そ
の水蒸気が器具外へ透過せず、このため長期間にわたっ
て所定の濃度が保たれ得る。しかも、本発明による検査
用器具は合成樹脂製であるので、運搬時、貯蔵時あるい
は使用時に衝撃を受けても破損の心配はない。また、ガ
スバリヤ−性が良好であるので、そのまま使用ずれば嫌
気性培養も可能である。
(Left below) Table 3 Tryptone 179 Soybean peptone 3Q Meat extract 3Q Yeast extract 5g Liver lysate 1g Glucose 2.5g Potassium hydrogen phosphate 2.5g Sodium chloride 5g Cystine hydrochloride 0.45g P-aminobenzoic acid o , 059 Sodium polyanetholesulfonate 0,35g Hemin o,oosg Agar 0.01g Gelatin i2g Distilled water i,ooomλ DH7,3±0.1 ■0Specific effects of the invention As described above, the present invention has the following effects: A gas barrier is formed by reacting a mixture of a silicon compound having the general formula (■) and a silicon compound having the general formula (■) on at least one of the inner and outer surfaces of a synthetic resin container body having at least one sealable opening. This is a testing instrument in which a testing agent is stored in a synthetic resin container formed with a continuous film, and the opening is closed with a punctureable plug member to form a sealed space inside. The gas permeability, particularly the oxygen gas permeability coefficient, is extremely low, so that gas permeation from the outside of the testing instrument into the instrument and from the inside of the instrument to the outside of the instrument is substantially eliminated. Therefore, when storing and using testing agents that are susceptible to oxygen deterioration, such as culture media and anticoagulants, the permeation of gas, especially oxygen, from outside the device into the device is virtually eliminated, resulting in a long period of time. There will be no deterioration of the testing agent over time. Furthermore, in the case of a test agent stored as an aqueous solution, even if water evaporates, the water vapor does not permeate outside the instrument, and therefore a predetermined concentration can be maintained for a long period of time. Moreover, since the testing instrument according to the present invention is made of synthetic resin, there is no fear of damage even if it is subjected to impact during transportation, storage, or use. In addition, since it has good gas barrier properties, anaerobic culture is also possible if used as is.

【図面の簡単な説明】 第1図は本発明による検査用器具の一例を示す断面図、
第2〈A〉〜2(C)図は第1図に示す検査用器の部分
拡大図、第3図は本発明で使用されるプラズマ処理装置
の一例を示す概略断面図、第4〜5図は減圧採取管の使
用状態を示す断面図である。 1・・・検査用器具、2・・・容器本体、2a、2b・
・・透明被膜、3・・・開口部、4・・・栓部材、 5
・・・空間、 5a・・・検査用薬剤。 第1図 (Cン 第3図
[BRIEF DESCRIPTION OF THE DRAWINGS] FIG. 1 is a sectional view showing an example of an inspection instrument according to the present invention;
Figures 2(A) to 2(C) are partially enlarged views of the inspection equipment shown in Figure 1, Figure 3 is a schematic sectional view showing an example of the plasma processing apparatus used in the present invention, and Figures 4 to 5. The figure is a sectional view showing the state in which the vacuum collection tube is used. 1... Inspection equipment, 2... Container body, 2a, 2b.
...Transparent film, 3...Opening, 4...Plug member, 5
...Space, 5a...Test drug. Figure 1 (C-Figure 3)

Claims (9)

【特許請求の範囲】[Claims] (1)少なくとも一個所に密閉可能な開口部で・1゜す
る合成樹脂製容器本体の内表面または外表面の少なくと
も〜方の表面゛に一般式I (ただし、式中、mは1〜5の整数である。〉を有する
ケイ素化合物と一般式■ (ただし、式中、nは1〜5の整数であり、またR1お
よびR2は炭素原子数1〜4のアルキルまたはアルコキ
シ基、フェニル基または水酸基であるが、R1およびR
2が同時に水酸基であることはない、)を有するケイ素
化合物の混合物を反応させてガスバリヤ−性の連続した
被膜を形成してなる合成樹脂製容器に検査用薬剤を収納
し、前記開口部を穿刺可能な栓部材で閉塞し内部に密封
空間を形成してなる検査用器具。
(1) At least one sealable opening on at least one surface of the inner or outer surface of the synthetic resin container body having a diameter of 1° with the general formula I (where m is 1 to 5 is an integer of 1 to 4 carbon atoms, and a silicon compound having the general formula Although it is a hydroxyl group, R1 and R
A test agent is stored in a synthetic resin container made by reacting a mixture of silicon compounds having a hydroxyl group (2 and 2 are not hydroxyl groups at the same time to form a continuous film with gas barrier properties), and the opening is punctured. An inspection instrument that is closed with a plug member to form a sealed space inside.
(2)前記合成樹脂製容器本体が透明合成樹脂製である
特許請求の範囲第1項に記載の検査用器具。
(2) The testing instrument according to claim 1, wherein the synthetic resin container body is made of transparent synthetic resin.
(3)前記被膜が透明被膜である特許請求の範囲だ第2
項に記載の検査用器具。
(3) The second claim is that the coating is a transparent coating.
Inspection equipment described in Section.
(4)前記被膜は膜厚が0.01〜2.0μmである特
許請求の範囲第1項ないし第3項のいずれか一つに記載
の検査用器具。
(4) The testing instrument according to any one of claims 1 to 3, wherein the coating has a thickness of 0.01 to 2.0 μm.
(5)一般式Iにおけるmが1〜5の整数であり、かつ
一般式πにおけるnが1〜5の整数であり、またR1お
よびR2が炭素原子数1〜4のアルキル基または水酸基
である特許請求の範囲第1項に記載の検査用器具。
(5) m in the general formula I is an integer of 1 to 5, and n in the general formula π is an integer of 1 to 5, and R1 and R2 are an alkyl group or a hydroxyl group having 1 to 4 carbon atoms. An inspection instrument according to claim 1.
(6)一般式πにおけるR1が炭素原子数1〜2のアル
キル基であり、かつR2が水酸基である特許請求の範囲
第5項に記載の検査用器具。
(6) The testing instrument according to claim 5, wherein R1 in the general formula π is an alkyl group having 1 to 2 carbon atoms, and R2 is a hydroxyl group.
(7)検査用薬剤が酸化性物質である特許請求の範囲第
1項ないし第6項のいずれか一つに記載の検査用器具。
(7) The testing device according to any one of claims 1 to 6, wherein the testing agent is an oxidizing substance.
(8)酸化生物質が液体ないしゲル状培地である特許請
求の範囲第7項に記載の検査用器具。
(8) The testing instrument according to claim 7, wherein the oxidant is a liquid or gel-like medium.
(9)酸化生物質が抗凝固剤である特許請求の範囲第7
項に記載の検査用器具。 く10)密閉空間が大気圧により減圧状態である特許請
求の範囲第1項に記載の検査用器具。
(9) Claim 7 in which the oxidant is an anticoagulant
Inspection equipment described in Section. (10) The testing instrument according to claim 1, wherein the closed space is in a reduced pressure state due to atmospheric pressure.
JP59092936A 1984-05-11 1984-05-11 Inspection apparatus Pending JPS60237360A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59092936A JPS60237360A (en) 1984-05-11 1984-05-11 Inspection apparatus
DE8585105778T DE3584188D1 (en) 1984-05-11 1985-05-10 METHOD FOR PRODUCING A SYNTETIC RESIN CONTAINER.
EP19850105778 EP0164583B1 (en) 1984-05-11 1985-05-10 Method for manufacture a container made of synthetic resin
US07/018,051 US4735832A (en) 1984-05-11 1987-02-24 Container made of synthetic resin and method for manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59092936A JPS60237360A (en) 1984-05-11 1984-05-11 Inspection apparatus

Publications (1)

Publication Number Publication Date
JPS60237360A true JPS60237360A (en) 1985-11-26

Family

ID=14068362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59092936A Pending JPS60237360A (en) 1984-05-11 1984-05-11 Inspection apparatus

Country Status (1)

Country Link
JP (1) JPS60237360A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650969A (en) * 1992-05-13 1994-02-25 Becton Dickinson & Co Blood-gathering tube assembly

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716867B2 (en) * 1975-11-25 1982-04-07
JPS5716866B2 (en) * 1976-04-13 1982-04-07

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716867B2 (en) * 1975-11-25 1982-04-07
JPS5716866B2 (en) * 1976-04-13 1982-04-07

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650969A (en) * 1992-05-13 1994-02-25 Becton Dickinson & Co Blood-gathering tube assembly

Similar Documents

Publication Publication Date Title
US4735832A (en) Container made of synthetic resin and method for manufacture thereof
US4885077A (en) Composite membrane, method for its preparation and electrolyte sensor including same
US4410492A (en) Sterilizing method incorporating recirculation of chamber atmosphere
US4337223A (en) Sterilizing apparatus incorporating recirculation of chamber atmosphere
US6460405B1 (en) Method for measuring gas leakage from sealed packages
US2672431A (en) Means for performing microbiological assays of aerosols and hydrosols
GB1578917A (en) Transducers
CA2359258A1 (en) Medical article having blood-contacting surface
JPH0222340B2 (en)
JPS60237360A (en) Inspection apparatus
WO2001087359A1 (en) Method for manufacturing sealing tool sterilized with gaseous hydrogen peroxide
JP2004103271A (en) Separator for fuel cell and surface treatment method of same
JPS60236630A (en) Vacuum blood sampling tube and its production
JPS60236651A (en) Drug container
WO2018164453A1 (en) Sterilizing packaging container for sealing and storing sterilizing agent
JP3149004B2 (en) Pinhole inspection method for sealed packaging bags
JPS60240647A (en) Vessel made of synthetic resin and manufacture thereof
JPH0561934B2 (en)
JPS60225540A (en) Vacuum blood sampler and its production
CN215114999U (en) Device for manufacturing aseptic package tightness detection positive reference sample
JP2781777B2 (en) Blood collection test tube assembly
JPS6248188B2 (en)
JP3252647B2 (en) Liquid processor
JPH0743267A (en) Sealing apparatus for moisture measurement operating unit
JP2995724B2 (en) Packaging method for synthetic resin blood collection tubes